Law360, Washington (June 04, 2012, 4:43 PM ET) -- A Massachusetts federal judge on Friday pared down a $421 million False Claims Act employee whistleblower case that alleged pharmaceutical company Organon USA Inc. operated a kickback scheme with two long-term care pharmacies to overcharge Medicaid for the company's antidepressant Remeron.
While U.S. District Judge Rya W. Zobel didn't dismiss all claims against Organon, Omnicare Inc. or PharMerica Inc., she dismissed a large swath of federal, state and local claims against each of the three defendants, noting that the relators in the qui tam case hadn't...
Judge Trims $421M Medicaid Kickback Suit Against Organon
To view the full article, take a free trial now.
